OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
54
Results
Show all
Save search
Copy query
Show results for
Unknown
(54)
Publication Date
Release Date
2023
(9)
2020
(9)
2022
(6)
2015
(6)
2021
(5)
2018
(4)
2014
(3)
2024
(2)
2019
(2)
2017
(2)
2025
(1)
2016
(1)
2013
(1)
2012
(1)
2011
(1)
2008
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Using synchrotron high-resolution powder X-ray diffraction for the structure determination of a new cocrystal formed by two active principle ingredients.
Not available
S-EPMC10844954
|
biostudies-literature
Cite
A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma.
Not available
S-EPMC4647878
|
biostudies-literature
Cite
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study.
Not available
S-EPMC4478976
|
biostudies-literature
Cite
Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma.
Not available
S-EPMC7761985
|
biostudies-literature
Cite
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.
Not available
S-EPMC3341152
|
biostudies-literature
Cite
New Strategies to Overcome Present CRISPR/Cas9 Limitations in Apple and Pear: Efficient Dechimerization and Base Editing.
Not available
S-EPMC7795782
|
biostudies-literature
Cite
Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury.
Not available
S-EPMC9505977
|
biostudies-literature
Cite
PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.
Not available
S-EPMC6599836
|
biostudies-literature
Cite
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Not available
S-EPMC10046214
|
biostudies-literature
Cite
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's).
Not available
S-EPMC5424317
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets